Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cognitive impairment among different clinical courses of multiple sclerosis.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
The fatigue-motor performance paradox in multiple sclerosis.
Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer Thickness in NMO Patients.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals with Multiple Sclerosis.
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.

Pages